Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

COALIGN INNOVATIONS ACCULIF XL IBF CAGE

K-Number: K131443 · 2013-06-19

ApplicantCoalign Innovations, Inc.
Decision Date2013-06-19
Product CodeMAX
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

COALIGN INNOVATIONS ACCULIF XL IBF CAGE is the device name listed in this FDA 510(k) record. The listed applicant is Coalign Innovations, Inc.. It received FDA 510(k) clearance on 2013-06-19 under 510(k) number K131443. The device is classified under product code MAX. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the COALIGN INNOVATIONS ACCULIF XL IBF CAGE?

COALIGN INNOVATIONS ACCULIF XL IBF CAGE is a medical device that received FDA 510(k) clearance on 2013-06-19. The listed applicant is Coalign Innovations, Inc.. The 510(k) number is K131443.

When did COALIGN INNOVATIONS ACCULIF XL IBF CAGE receive FDA 510(k) clearance?

COALIGN INNOVATIONS ACCULIF XL IBF CAGE received FDA 510(k) clearance on 2013-06-19, under 510(k) number K131443.

Who is the listed applicant for COALIGN INNOVATIONS ACCULIF XL IBF CAGE?

The FDA 510(k) record lists Coalign Innovations, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for COALIGN INNOVATIONS ACCULIF XL IBF CAGE?

The FDA product code for COALIGN INNOVATIONS ACCULIF XL IBF CAGE is MAX.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Coalign Innovations, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K132505ACCULIF TL AND PL CAGEK130194ACCULIF XL CAGEK123281ACCULIF TL-PEEK CAGEK123752ACCULIF TL AND PL CAGEK121683ACCULIF TL CAGEK113465ACCULIF TL CAGE

View all 9 devices →

Related Devices (Code: MAX)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K261049SCALA® TLSpineart SAK261430TruLift Expandable SystemLife Spine, Inc.K253011Catalyft PL Expandable Interbody SystemMedtronic Sofamor Danek USA, Inc.K261020Symmetrix™ L Spinal SystemMedtronic Sofamor Danek USA, Inc.K253420Admiral ACP System; Explorer TO System; Laminoplasty System; Manta Ray TDF Spacer; Meridian Interbody System; Meridian Anterior Plate System; Reef L Interbody System; Reef TO/TA System; Regatta Lateral System; Regatta Lateral Plate System; Shoreline ACS Interbody System; Shoreline Threaded TruProfile Plate; Shoreline RT Interbody System; Vu Mesh; WaveForm A Interbody System; WaveForm C Interbody System; WaveForm L Interbody System; WaveForm TA Interbody System; WaveForm TO Interbody SySeaSpine Orthopedics CorporationK253151Fule Interbody Fusion Cage SystemBeijing Fule Science & Technology Development Co., Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑